相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART
Luciano Potena et al.
TRANSPLANTATION (2018)
Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity
Khaldoun Ghazal et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2018)
Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR
M. D. Parkes et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Epigenetic Networks Regulate the Transcriptional Program in Memory and Terminally Differentiated CD8+ T Cells
Ramon M. Rodriguez et al.
JOURNAL OF IMMUNOLOGY (2017)
CD8+ effector memory T cells induce acute rejection of allogeneic heart retransplants in mice possibly through activating expression of inflammatory cytokines
Gang Du et al.
EXPERIMENTAL CELL RESEARCH (2017)
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report 2017; Focus Theme: Allograft ischemic time
Daniel. C. Chambers et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time
Lars H. Lund et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study
A. K. Andreassen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Phenotypical characterization of regulatory T cells in humans and rodents
A. L. Rodriguez-Perea et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells
Charlotte M. Huijts et al.
CLINICAL IMMUNOLOGY (2016)
Clinical potential of DNA methylation in organ transplantation
Fleur S. Peters et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation
Kristen N. Pollizzi et al.
NATURE IMMUNOLOGY (2016)
Effect of everolimus initiation and early calcineurin inhibitor withdrawal on myocardial FOXP3+regulatory T cells in heart transplantation
Kiran Mirza et al.
TRANSPLANT IMMUNOLOGY (2016)
mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function
Nyamdelger Sukhbaatar et al.
TRENDS IN IMMUNOLOGY (2016)
Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
Karin Boer et al.
CLINICAL EPIGENETICS (2016)
Oscillatory mTOR inhibition and Treg increase in kidney transplantation
M. Sabbatini et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
Kristen N. Pollizzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Effect of Early Conversion to Everolimus Together With Prophylaxis With Valganciclovir in the Prevention of Cytomegalovirus Infection in Heart Transplant Recipients
B. Diaz Molina et al.
TRANSPLANTATION PROCEEDINGS (2015)
Targeting CD8 T-cell metabolism in transplantation
Michelle Yap et al.
FRONTIERS IN IMMUNOLOGY (2015)
Regulation of innate immune cell function by mTOR
Thomas Weichhart et al.
NATURE REVIEWS IMMUNOLOGY (2015)
From Truly Naive to Exhausted Senescent T Cells: When Markers Predict Functionality
Anis Larbi et al.
CYTOMETRY PART A (2014)
Limited Efficacy of Immunosuppressive Drugs on CD8+T Cell-Mediated and Natural Killer Cell-Mediated Lysis of Human Renal Tubular Epithelial Cells
Martijn W. H. J. Demmers et al.
TRANSPLANTATION (2014)
Differential Effect of Everolimus on Progression of Early and Late Cardiac Allograft Vasculopathy in Current Clinical Practice
M. Masetti et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial
H. J. Eisen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Epigenetic modulation of the immune function A potential target for tolerance
Beatriz Suarez-Alvarez et al.
EPIGENETICS (2013)
DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant
Ramon M. Rodriguez et al.
PLOS ONE (2013)
Increased Numbers of Circulating CD8 Effector Memory T Cells before Transplantation Enhance the Risk of Acute Rejection in Lung Transplant Recipients
David San Segundo et al.
PLOS ONE (2013)
The peripheral NK cell repertoire after kidney transplantation is modulated by different immunosuppressive drugs
Christine Neudoerf et al.
FRONTIERS IN IMMUNOLOGY (2013)
CD4+CD25+CD127low/- T Cells: A More Specific Treg Population in Human Peripheral Blood
Ning Yu et al.
INFLAMMATION (2012)
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study
Luciano Potena et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Terminally Differentiated CD8+ Temra Cells Are Associated With the Risk for Acute Kidney Allograft Rejection
Michiel G. H. Betjes et al.
TRANSPLANTATION (2012)
DNA methylation: a promising landscape for immune system-related diseases
Beatriz Suarez-Alvarez et al.
TRENDS IN GENETICS (2012)
Intragraft Regulatory T Cells in Protocol Biopsies Retain Foxp3 Demethylation and Are Protective Biomarkers for Kidney Graft Outcome
O. Bestard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Mycophenolic Acid Inhibits Natural Killer Cell Proliferation and Cytotoxic Function: A Possible Disadvantage of Including Mycophenolate Mofetil in the Graft-Versus-Host Disease Prophylaxis Regimen
Kinya Ohata et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
A Central Role for mTOR Kinase in Homeostatic Proliferation Induced CD8+ T Cell Memory and Tumor Immunity
Qingsheng Li et al.
IMMUNITY (2011)
The Evolving Role of mTOR Inhibition in Transplantation Tolerance
Gearoid McMahon et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
Greg M. Delgoffe et al.
NATURE IMMUNOLOGY (2011)
Comparative Transcriptional and Phenotypic Peripheral Blood Analysis of Kidney Recipients Under Cyclosporin A or Sirolimus Monotherapy
S. Brouard et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Rapamycin and MPA, But Not CsA, Impair Human NK Cell Cytotoxicity Due to Differential Effects on NK Cell Phenotype
D. N. Eissens et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
A Versatile Role of Mammalian Target of Rapamycin in Human Dendritic Cell Function and Differentiation
Michael Haidinger et al.
JOURNAL OF IMMUNOLOGY (2010)
Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study
Heather Ross et al.
TRANSPLANT INTERNATIONAL (2010)
Number of Peripheral Blood Regulatory T Cells and Lymphocyte Activation at 3 Months After Conversion to mTOR Inhibitor Therapy
D. San Segundo et al.
TRANSPLANTATION PROCEEDINGS (2010)
The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity
M. D. Saeemann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Relationship between CD107a expression and cytotoxic activity
Esin Aktas et al.
CELLULAR IMMUNOLOGY (2009)
The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Greg M. Delgoffe et al.
IMMUNITY (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
Immunoregulatory functions of mTOR inhibition
Angus W. Thomson et al.
NATURE REVIEWS IMMUNOLOGY (2009)
The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Sokol Haxhinasto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus
James A. Hill et al.
TRANSPLANTATION (2007)
Clinical experience with Certican® (everolimus) in maintenance heart transplant patients at the Medical University of Vienna
A Zuckermann
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Clinical experience with Certican® (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin
H Lehmkuhl et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
HJ Eisen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
